Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USP Adds Heparin, Glycerin Tests While FDA, Army Labs Try New Test Methods

This article was originally published in The Gold Sheet

Executive Summary

New tests raise bar against adulterants, counterfeits as USP adds instrumental methods for heparin ID test and drops compromised sheep clotting assay, while revising the glycerin ID test to include a DEG limit and making overtures to FDA's incoming leadership to strengthen their partnership. Meanwhile, FDA's forensic lab gives some insight into its methods for catching drug counterfeiters, the agency's St. Louis lab explains how it found adulterants in ED supplements, and the Army shares its methods for spotting biowarfare pathogens.

You may also be interested in...



Five Years Later, Legacy Biologics Still Face ‘Next Heparin’ Risks

Several factors continue to slow efforts to modernize legacy biologics’ compendial monographs against fake ingredients like the ones someone put in heparin in 2008. Hyaluronate, the ‘poster child’ for monograph modernization; New NDAs for pancreatin create new modernization challenges; Heparin maker vertically integrates to prevent adulteration.

Drug Manufacturers Find They Must Trust But Verify Anti-Counterfeiting Methods

Portable anti-counterfeiting methods must be verified, experts say. Variance among handheld spectrometers and raw materials could foil dream of industry-wide spectral Raman library. What happens when you wave two wands? Statistical tools might help. Raman just one of four technologies available for handhelds. Merck using portable Raman to safeguard supply chain. How Merck traced TV boxes of Fosamax to China. Merck's point-and-shoot approach. New DEG adulteration screening tests burden toothpaste maker. NIH launches photo library.

Drug Manufacturers Find They Must Trust But Verify Anti-Counterfeiting Methods

Portable anti-counterfeiting methods must be verified, experts say. Variance among handheld spectrometers and raw materials could foil dream of industry-wide spectral Raman library. What happens when you wave two wands? Statistical tools might help. Raman just one of four technologies available for handhelds. Merck using portable Raman to safeguard supply chain. How Merck traced TV boxes of Fosamax to China. Merck's point-and-shoot approach. New DEG adulteration screening tests burden toothpaste maker. NIH launches photo library.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS000332

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel